Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ARYA

ARYA Sciences Acquisition Corp III (ARYA) Stock Price, News & Analysis

About ARYA Sciences Acquisition Corp III Stock (NASDAQ:ARYA)

Advanced Chart

Key Stats

Today's Range
$10.77
$11.25
50-Day Range
$9.91
$11.16
52-Week Range
$9.82
$25.89
Volume
366,228 shs
Average Volume
320,123 shs
Market Capitalization
$186.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

ARYA Sciences Acquisition Corp III does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in New York, New York.

Receive ARYA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ARYA Sciences Acquisition Corp III and its competitors with MarketBeat's FREE daily newsletter.

ARYA Stock News Headlines

Oaktree Acquisition Corp. III Life Sciences (OACCU)
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. Now… as new tariffs take effect, gold is breaking records again. You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER.
Mphasis appoints Ajay Arya to head M&A
Nautilus Biotechnology Inc (NAUT)
See More Headlines

ARYA Stock Analysis - Frequently Asked Questions

ARYA Sciences Acquisition Corp III (ARYA) raised $125 million in an initial public offering on Friday, August 7th 2020. The company issued 12,500,000 shares at a price of $10.00 per share. Jefferies and Goldman Sachs served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that ARYA Sciences Acquisition Corp III investors own include Ampio Pharmaceuticals (AMPE), bluebird bio (BLUE), Forte Biosciences (FBRX), Navidea Biopharmaceuticals (NAVB), Outlook Therapeutics (OTLK), Electrameccanica Vehicles (SOLO) and Sequential Brands Group (SQBG).

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
Holding & Other Investment Offices
Sub-Industry
N/A
Current Symbol
NASDAQ:ARYA
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$0.30 per share
Price / Book
37.20

Miscellaneous

Free Float
N/A
Market Cap
$186.48 million
Optionable
Not Optionable
Beta
N/A
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:ARYA) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners